A surgical showdown: can a newer bariatric procedure outsmart blood sugar drops?

NCT ID NCT07747779

First seen Aug 05, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This trial compares two weight-loss surgeries in people with severe obesity (BMI 50-60). One is the standard Roux-en-Y gastric bypass, the other a newer sleeve gastrectomy with duodenojejunal bypass. The goal is to see which procedure leads to healthier hormone responses after meals, potentially reducing the risk of low blood sugar (hypoglycemia) that can occur after bariatric surgery. By measuring gut hormones like GLP-1 and insulin, researchers hope to understand how each surgery affects metabolism and weight loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Two surgical procedures: Roux-en-Y gastric bypass (standard) and sleeve gastrectomy with duodenojejunal bypass (novel)
What this could lead to
If the newer surgery causes fewer blood sugar drops after meals, it could become a preferred option for people with super obesity, offering safer long-term weight loss.
What could go wrong
This is a small, early study, so results may not apply to everyone. Both surgeries carry risks, and the newer procedure may not prove better in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • King Chulalongkorn Memorial Hospital

    RECRUITING

    Pathum Wan, Bangkok, 10330, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.